ACHP Statement on 2027 Medicare Drug Negotiations
As the only national payer group to push for comprehensive drug reforms, ACHP believes that it is past time for pharmaceutical companies to answer for their pricing practices.
As the only national payer group to push for comprehensive drug reforms, ACHP believes that it is past time for pharmaceutical companies to answer for their pricing practices.
We are pleased that CMS is anticipating a new risk-adjustment model calibrated on MA encounter data, reflected in our MA for Tomorrow initiative.
ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.